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Increased parasympathetic tone achieved with endurance 
training may provide cardioprotection after menopause. To 
compare heart rate variability (HRV) from rest through maximal 
exercise and recovery in trained postmenopausal women. Thirty-
six postmenopausal women who self-reported training at either 
moderate (MOD; 3-5.9 METS; 58.9±4.4 year) or vigorous (VIG; 
>6 METS; 59.7±5.2 year) intensities participated. HRV was 
measured for 5 min in the supine position, in the last minute of 
the VO2max test and after 2 min of active recovery. HRV in MOD 
and VIG was compared using a factorial ANOVA with repeated 
measures on time. MOD and VIG responded similarly over the 
three time periods for root mean square of sequential deviations 
(rMSSD), and high (HF) and low frequency (LF) power (p>0.05). 
Maximal exercise lowered rMSSD (3.3±0.08 vs. 1.2±0.06) and 
lnLF (4.1±0.05 vs. 3.3±0.13) and increased lnHF (3.3±0.14 vs. 
4.0±0.10; p<0.01) from resting. However, active recovery 
restored lnHF (3.3±0.11) and lnLF (4.1±0.08) from maximal 
values (p<0.01). Our findings suggest that moderate and 
vigorous exercise training may enhance HRV recovery following 
one bout of maximal exercise in older women. 
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An imbalance favoring sympathetic tone has 
been shown to increase cardiovascular disease risk in 
postmenopausal women (Gautam et al. 2011).  
A noninvasive measure of autonomic nervous system 
dysfunction is heart rate variability (HRV). As women 
transition through menopause, augmented sympathetic 
function has been shown to result in vascular damage and 
increased mortality (Sanchez-Barajas et al. 2015). This 
loss of parasympathetic dominance and corresponding 
arrhythmia protection is reflected by changes in the high 
frequency power domain of HRV (Tsuji et al. 1994). 
Although HRV declines with age, physically 
active women have higher HRV than sedentary women 
(Davy et al. 1998). Reland et al. (2003) reported  
an enhanced sinus node response to incremental exercise 
in the highly active group compared to low and moderate, 
suggesting that exercise intensity may attenuate the 
effects of age on cardiovascular disease risk. 
Additionally, post-exercise HRV dynamics (vagal 
reactivation) have been shown to be intensity-dependent 
(Kaikkonen et al. 2007). 
Assessment of HRV post-exercise is a valuable 
tool to monitor autonomic nervous system (ANS) 
dysfunction and potential cardiac abnormalities (Pecanha 
et al. 2017). The normal increase in heart rate during 
exercise occurs through parasympathetic withdrawal and 
reduced HRV. However, a prolonged delay in the 
restoration of HRV can predispose the heart to 
arrhythmias (Brown and Brown 2007). 
The purpose of this study was to compare the 
HRV response from rest through maximal exercise and 
recovery in trained postmenopausal women. 






The study design has been described in detail 
elsewhere (Orri et al. 2017). Briefly, thirty-six 
postmenopausal women volunteered from the 
community. The women self-reported their exercise 
training intensity as either (1) Vigorous – masters level 
swimmers, cyclists or runners who trained >6 METS 
(metabolic equivalents of oxygen); or (2) Moderate – 
recreational swimmers or cyclists who trained at  
3-6 METS. All women were exercising at their level for  
a minimum of 6 months prior to enrolling in the study 
(Thompson 2010). The Institutional Review Board at the 
University approved the study protocol. Written consent 
was obtained from all participants. 
 
Exclusion criteria 
Women who were taking β-blockers or 
antiarrhythmic drugs were excluded due to their effect on 
heart rate variability. All women were healthy, with one 
or fewer risk factors for cardiovascular disease according 
to the American College of Sports Medicine (ACSM) 
(Thompson 2010). Women who were taking hormone 
therapy (HT) were enrolled due to the lack of influence of 
estrogen on HRV as shown by Harvey et al. (2015). 
There were five women in the MOD group who were 
taking HT and 1 in the VIG group. As such, two analyses 
were performed on the CRP and HRV data, one with the 
HT performers included, and the other without. It was 
found that HT did not influence these outcome variables. 
 
Procedures 
The measurements were performed at the 
Exercise Physiology Laboratory at the University at least 
24 h following the participants’ last regular exercise bout. 
They were asked to refrain from ingesting food, alcohol, 
or caffeine within three hours of testing (Thompson 
2010). Testing time was not standardized due to lack of 
flexibility in participant’s and laboratory schedules. 
 
Aerobic capacity 
A heart rate monitor (Polar RS800cx, Finland) 
transmitter was placed on the participant’s chest and  
a receiver (watch) was attached to their wrist. For the 
resting HRV assessment, participants lay supine for 
5 min during normal breathing. After the heart rate 
stabilized, the HRV was measured for 5 min (Seiler et al. 
2007). Following the resting measurements, participants 
had their VO2max measured on the treadmill using the 
Bruce protocol. Expired gases were collected 
continuously using a calibrated metabolic cart 
(ParvoMedics True Max 2400, Sandy UT, USA). The 
criteria for VO2max were one of the following: failure of 
heart rate to increase with further increases in exercise 
intensity, a plateau in oxygen uptake or failure to increase 
oxygen uptake by 150 ml•min-1 with increased workload, 
a respiratory exchange ratio >1.1, or a rating of perceived 
exertion (RPE) >17 on the 6-20 scale (Thompson 2010). 
Following the exercise test, subjects walked at  
a self-selected pace (2.0 mph) for five minutes. Heart rate 
variability was measured at VO2max, and minutes 1 and 
2 following cessation of exercise. The heart rate recovery 
(HRR) was calculated by subtracting the heart rate at 
minutes 1 and 2 from HRmax. 
 
Outcome measures 
The HRV analysis included mean heart rate, 
mean RR (interbeat) interval, the root mean square of 
sequential deviations (rMSSD), and the percentage of all 
sequential RR deviations exceeding 50 ms (pNN50) in 
the time domain, plus high (HF) and low frequency (LF) 
power in the frequency domain (Seiler et al. 2007). 
 
Statistical analysis 
Normality was checked with the Shapiro-Wilk 
test. Variables with a skewed distribution were log-
transformed prior to analysis. Comparison of HRV in 
MOD and VIG was performed using a factorial ANOVA 
with repeated measures on time. The level of significance 
was set at p<0.05. Statistical analyses were performed 




Table 1 shows the anthropometric and VO2max 
data. Of the 18 women in the VIG group, there were  
13 master swimmers, 2 competitive rowers, 2 cyclists and 
1 runner. The MOD group had 14 recreation swimmers,  
1 runner, and 3 women who worked out at the gym 
(elliptical, walking). The VIG group had higher waist 
circumference compared to MOD (p<0.05). Heart rate 
recovery was equal and rapid in both MOD and VIG 
(p>0.05). No other differences were found (p>0.05). 
There were no differences between MOD and 
VIG for resting HRV (p>0.05). Figure 1 (a, b, c) shows 
that maximal exercise lowered lnLF (log transformed 
value of low frequency) and rMSSD and increased lnHF 
2018  Heart Rate Variability After Exercise in Postmenopausal Women    705  
 
from resting. Two minutes of active recovery on the 
treadmill significantly restored both frequency indices 
from maximal values (p<0.01). Figure 2 is an example of 
HRV for one VIG participant at preexercise, VO2max 
(time=11:18) and active recovery. There is greater 
variability in the RR interval preexercise with  
a corresponding lower heart rate. As the participant 




Table 1. Anthropometric and VO2max data. 
 
 Moderate (MOD; n=18) Vigorous (VIG; n=18) 
Age (year) 58.9 ± 4.4 59.7 ± 5.2 
BMI (kg/m2) 23.0 ± 2.7 24.6 ± 3.0 
WC (cm) 74.1 ± 5.0 81.3 ± 9.6a 
BF (%) 23.8 ± 4.7 24.5 ± 3.9 
VO2max (ml/kg/min) 32.4 ± 5.7 34.5 ± 5.1 
HRmax (bpm) 163.9 ± 10.6 162.1 ± 10.9 
HRR min 1 (bpm) 24.4 ± 9.3 22.7 ± 9.0 
HRR min 2 (bpm) 43.4 ± 9.6 45.2 ± 11.4 
 
All values are mean ± SD; unadjusted values. MOD, trained at 3.0-5.9 METS; VIG, >6.0 METS; BMI, body mass index; WC, waist 






Fig. 1. The effect of maximal exercise and recovery on (A) LF, (B) HF and (C) rMSSD (logarithmic transformed). (HF, high frequency; 
LF, low frequency; rMSSD, root mean square of sequential deviations). 
 







Fig. 2. An example of HRV for one VIG participant at preexercise, VO2max (11:18) and active recovery. (A) Corrected RR interval time 
series; (B) Frequency histogram at preexercise, VO2max (11:18) and active recovery. (FFT, fast Fourier transform; PSD, power 





This observational study showed that vigorous 
exercise was similar to moderate over the three time 
periods for rMSSD, and high and low frequency power 
values. Frequency domain variables returned to baseline 
values by 2 min after maximal exercise in both MOD and 
VIG. To our knowledge, this is one of the few studies to 
investigate HRV during maximal exercise and recovery 
in trained postmenopausal women. 
The LF decrease at VO2max was equal between 
groups. Our findings are in accordance with Perini et al. 
(2002) who reported decreases in LF above 0.7 l/min 
during the graded cycle ergometer test following 8 weeks 
of aerobic training in men (75.1±4.0 year) and women 
(72.9±3.2 year). Cottin et al. (2008) reported that 
decreases in LF may be as result of vagal withdrawal and 
saturation of the cardiac β-receptors by catecholamines. 
Our results are in line with a study by Bailon and 
colleagues (2013) who found a similar LF decrease, 
followed by a rapid increase during recovery in young 
men. Imai et al. (1994) also found similar results in 
young athletes, and suggested that training status 
influences vagal recovery. In the present study, despite 
self-reporting their training status, both MOD and VIG 
had cardiorespiratory fitness levels that were at or above 
the “good” levels, as determined by ACSM (Thompson, 
2010). These results suggest that training at or above  
6 METS has a positive influence on vagal reactivation 
during postmenopause. 
We also found an increase in HF at VO2max, 
with no difference between groups. The HF component 
reflects the respiratory effort of the performer and is  
an indicator of the vagal activity of the heart (Vanderlei 
et al. 2009). Our findings are contrary to Reland et al. 
(2003) who reported decreases in HF only in their active 
group who self-reported their physical activity 
(3,445±409.3 kcal/week). They further added that 
training intensity did not affect respiratory drive. Our 
participants had higher VO2max levels (MOD 32.4±5.7; 
VIG 34.5±5.1 ml/kg/min) that were directly measured 
with expired gases. Previous studies have suggested HF 
increases were a result of hyperventilation and 
mechanical stretching of the sinus node (Cottin et al. 
2008). Blain et al. (2005) reported that the periodic 
stretching of the sinus node seen during intense exercise 
occurs independent of pressure influences on the atria 
(Blain et al. 2005). Freeman (2006) hypothesized that the 
interplay between parasympathetic and sympathetic 
control may be due to baroreceptor function. 
In the present study, two minutes of active 
recovery restored the HRV frequency indices to resting 
values. The HRV values in our study were reestablished 
much quicker than in previous studies on older men and 
women. Our results are also in contrast to Harvey et al. 
(2016) who reported a delay in ANS recovery after 
2018  Heart Rate Variability After Exercise in Postmenopausal Women    707  
 
45 min of treadmill exercise at 60 % VO2peak, in 
sedentary postmenopausal women and no effect of 
exercise in premenopausal women. Our participants 
exercised at over 100 % of age-predicted max heart rate 
(MOD 163.9, VIG 162.1 bpm) with a heart rate recovery 
of over 70 % after 2 min. The ability to restore autonomic 
modulation is imperative, given the association with 
cardiac arrhythmias post-exercise (Brown and Brown 
2007). 
The efficacy of HRV in the prediction of sudden 
cardiac death is well-documented (Huikuri et al. 1999). 
As women transition through menopause, they experience 
an immediate decrease in HRV from the loss of 
estrogen’s influence on cross bridge formation and 
cardiac contractility (Brockbank et al. 2000). Further, 
women experiencing hot flushes have been shown to 
have increased sympathetic dominance and reduced 
parasympathetic tone as the low estrogen affects the 
central nervous system (Hautamaki et al. 2011). In spite 
these cardiac changes, the influence of HT on HRV has 
been equivocal. Perseguini et al. (2014) reported that the 
women not undergoing HT had improved HRV, through 
reduced sympathetic and increased parasympathetic 
modulation, compared to the participants who were 
taking HT. In our study, we found no differences in the 
HRV outcome variables, despite five women in the MOD 
group who were on HT. Given the lack of consistency of 
benefit of HT on HRT, along with the findings of the 
Women’s Health Initiative (Rossouw et al. 2002), the 
importance of endurance training throughout the aging 
process cannot be understated. Okazaki et al. (2005) 
found that the HRV of masters athletes was similar to 
young control subjects. Further, their sedentary group 
increased their HRV after 1 year of training. The authors 
concluded that the enhanced HRV could potentially lower 
the risk of ventricular fibrillation. 
The reductions in HRV with age may only be 
partially offset with regular exercise. In a recent large 
cross-sectional study, Jandackova et al. (2016) reported 
that there was an age-dependent reduction in HRV, with 
no additional benefit of maintaining a physical activity 
level as suggested by the World Health Organization. 
However, the authors pointed out that the decreases in 
HRV indices such as standard deviation of normal  
RR intervals (SDNN) and LF were augmented in women 
experiencing cardiometabolic pathologies. A study by 
Uusitalo et al. (2004) found decreases in LF after 5 years 
of low intensity aerobic training (40-60 % VO2max) in 
older men (57.4 year). It is important to mention that their 
population was equally distributed between healthy and 
men with cardiovascular or other conditions requiring 
medication. The effect of detraining on HRV was 
explored by Sotiriou et al. (2013). They found that former 
professional soccer players who maintained their aerobic 
fitness had higher HRV time and frequency indices 
compared to inactive former athletes and controls. 
Moreover, the authors stressed that the improvements in 
autonomic modulation were essentially lost despite 
previous intensive training and competition at the elite 
level. 
In the present study, we demonstrated that the 
essential component to maintaining autonomic 
modulation throughout the aging process is an active 
lifestyle. Our VIG participants were competitive in 
swimming, rowing and cycling. Although most of our 
MOD participants were not performing interval training, 
their dedication to exercise resulted in cardioprotective 
benefits. Our results suggest that these lifestyle choices 
are crucial to the enhancement of HRV through and 
beyond menopause. 
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